Knowledge and News for the Global Fight Against Cancer.
Emerging from stealth on Wednesday, April 15, 2026, Beeline Medicines announced its official launch, fortified...
Johnson & Johnson, the global healthcare behemoth, announced a stellar first-quarter performance for 2026, significantly...
The recent clearance of Filspari (sparsentan) by the U.S. Food and Drug Administration (FDA) for...
Spyre Therapeutics, a prominent player in the inflammatory bowel disease (IBD) landscape, announced groundbreaking early...
The global health landscape is witnessing a profound shift as menopause, long relegated to hushed...
The Centers for Disease Control and Prevention (CDC) has formally published a new charter for...
Shanghai-based Oricell Therapeutics, a burgeoning force in the biotechnology sector, has successfully closed a pre-initial...
The U.S. Food and Drug Administration (FDA) has delivered a second significant blow to Replimune...
Shanghai-based Excalipoint Therapeutics has announced the successful closure of a substantial financing round totaling $68.7...
A new drug from Pfizer, atirmociclib, is emerging as a critical component of the pharmaceutical...
admin